Federica Bovo

1.7k total citations
18 papers, 342 citations indexed

About

Federica Bovo is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Federica Bovo has authored 18 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 10 papers in Molecular Medicine and 5 papers in Epidemiology. Recurrent topics in Federica Bovo's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Antibiotic Use and Resistance (4 papers). Federica Bovo is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Antibiotic Use and Resistance (4 papers). Federica Bovo collaborates with scholars based in Italy and Canada. Federica Bovo's co-authors include Paolo Gaibani, Simone Ambretti, Tiziana Lazzarotto, Donatella Lombardo, Michele Bartoletti, Linda Bussini, Pierluigi Viale, Gian María Rossolini, Tommaso Giani and Marco Coppi and has published in prestigious journals such as Scientific Reports, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Federica Bovo

18 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federica Bovo Italy 9 244 142 128 76 62 18 342
Hariharan Periasamy India 12 235 1.0× 156 1.1× 88 0.7× 72 0.9× 60 1.0× 19 332
Federica Sacco Italy 10 225 0.9× 115 0.8× 111 0.9× 86 1.1× 47 0.8× 28 300
Julia Guzmán-Puche Spain 9 277 1.1× 138 1.0× 130 1.0× 107 1.4× 28 0.5× 23 321
Valentina Galfo Italy 10 346 1.4× 205 1.4× 162 1.3× 115 1.5× 37 0.6× 18 443
Islam M. Ghazi United States 10 197 0.8× 129 0.9× 101 0.8× 96 1.3× 45 0.7× 35 320
Ángela Cano Spain 10 278 1.1× 138 1.0× 141 1.1× 118 1.6× 28 0.5× 24 326
G. Gallagher United States 4 271 1.1× 95 0.7× 131 1.0× 113 1.5× 74 1.2× 6 410
Maria C Losada United States 7 259 1.1× 275 1.9× 136 1.1× 105 1.4× 46 0.7× 15 430
Eleftheria Trikka‐Graphakos Greece 8 210 0.9× 140 1.0× 65 0.5× 126 1.7× 33 0.5× 12 347
Carmen Paz Oplustil Brazil 9 227 0.9× 83 0.6× 109 0.9× 132 1.7× 53 0.9× 23 377

Countries citing papers authored by Federica Bovo

Since Specialization
Citations

This map shows the geographic impact of Federica Bovo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Bovo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Bovo more than expected).

Fields of papers citing papers by Federica Bovo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Bovo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Bovo. The network helps show where Federica Bovo may publish in the future.

Co-authorship network of co-authors of Federica Bovo

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Bovo. A scholar is included among the top collaborators of Federica Bovo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Bovo. Federica Bovo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Palombo, Marta, Federica Bovo, Elena De Vecchi, et al.. (2023). Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021. Microbial Drug Resistance. 30(1). 50–54. 2 indexed citations
2.
Bovo, Federica, Tiziana Lazzarotto, Simone Ambretti, & Paolo Gaibani. (2023). Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae. Antibiotics. 12(3). 614–614. 10 indexed citations
5.
Gaibani, Paolo, Federica Bovo, Linda Bussini, et al.. (2023). Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients. Clinical Microbiology and Infection. 29(5). 654.e1–654.e4. 8 indexed citations
7.
Bovo, Federica, Donatella Lombardo, Tiziana Lazzarotto, Simone Ambretti, & Paolo Gaibani. (2022). Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020. Antibiotics. 11(11). 1621–1621. 8 indexed citations
8.
Gaibani, Paolo, Linda Bussini, Michele Bartoletti, et al.. (2022). Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient. Microorganisms. 10(4). 778–778. 10 indexed citations
9.
Gaibani, Paolo, Tommaso Giani, Federica Bovo, et al.. (2022). Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing. Antibiotics. 11(5). 628–628. 77 indexed citations
10.
Gaibani, Paolo, Federica Bovo, Linda Bussini, et al.. (2022). Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments. Journal of Antimicrobial Chemotherapy. 77(6). 1570–1577. 26 indexed citations
11.
Gaibani, Paolo, Donatella Lombardo, Linda Bussini, et al.. (2021). Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018. Antibiotics. 10(5). 536–536. 38 indexed citations
12.
Gaibani, Paolo, Elisa Viciani, Michele Bartoletti, et al.. (2021). The lower respiratory tract microbiome of critically ill patients with COVID-19. Scientific Reports. 11(1). 10103–10103. 48 indexed citations
13.
Pascale, Renato, Linda Bussini, Paolo Gaibani, et al.. (2021). Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study. Infection Control and Hospital Epidemiology. 43(4). 461–466. 70 indexed citations
14.
Trevisani, Marcello, et al.. (2019). Growth Potential of Listeria monocytogenes in Chef-Crafted Ready-to-Eat Fresh Cheese-Filled Pasta Meal Stored in Modified Atmosphere Packaging. Journal of Food Protection. 82(9). 1546–1552. 3 indexed citations
15.
Cesare, Alessandra De, Silvia Vitali, Marcello Trevisani, Federica Bovo, & Gerardo Manfreda. (2016). Microbiological and Modeling Approach to Derive Performance Objectives for Bacillus cereus Group in Ready‐to‐Eat Salads. Risk Analysis. 37(3). 408–420. 3 indexed citations
16.
Bovo, Federica, Alessandra De Cesare, Gerardo Manfreda, Susan Bach, & Pascal Delaquis. (2015). Fate of Salmonella enterica in a Mixed Ingredient Salad Containing Lettuce, Cheddar Cheese, and Cooked Chicken Meat. Journal of Food Protection. 78(3). 491–497. 9 indexed citations
17.
Pasquali, Frédérique, Pietro Rocculi, Alessandra De Cesare, et al.. (2014). New technologies to enhance quality and safety of table eggs: ultra-violet treatment and modified atmosphere packaging. Italian Journal of Food Safety. 3(4). 4462–4462. 1 indexed citations
18.
Pasquali, Frédérique, Alessandra De Cesare, Federica Bovo, Andrea Serraino, & Gerardo Manfreda. (2013). Relative accuracy, specificity and sensitivity of a 5′ nuclease Real-Time PCR assay for Salmonella detection in naturally contaminated pork cuts. Molecular and Cellular Probes. 28(4). 133–137. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026